585 related articles for article (PubMed ID: 26653888)
1. Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years.
Gu G; Huang H; Zhang L; Bi Y; Hu Y; Zhou YH
BMC Infect Dis; 2015 Dec; 15():560. PubMed ID: 26653888
[TBL] [Abstract][Full Text] [Related]
2. Incidence and seroprevalence of hepatitis E virus infection in pregnant women infected with hepatitis B virus and antibody placental transfer in infants.
Huang H; Xu C; Zhou X; Liu L; Dai Y; Xu B; Yang J; Chen T; Hu Y; Zhou YH
J Clin Virol; 2016 Sep; 82():84-88. PubMed ID: 27467017
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China.
Cong W; Sui JC; Zhang XY; Qian AD; Chen J; Zhu XQ
J Med Virol; 2015 Mar; 87(3):446-50. PubMed ID: 25164987
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence and risk factors of hepatitis E virus infection among children in China.
Meng QF; You HL; Wang WL; Zhou N; Dong W; Cong W
J Med Virol; 2015 Sep; 87(9):1573-7. PubMed ID: 25940435
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis E virus infection in pregnant women, Argentina.
Tissera G; Lardizabal MC; Torres SB; Fantilli AC; Martínez Wassaf MG; Venezuela F; Capra R; Balderramo DC; Travella C; Ré VE; Pisano MB
BMC Infect Dis; 2020 May; 20(1):368. PubMed ID: 32448132
[TBL] [Abstract][Full Text] [Related]
6. High seroprevalence of hepatitis E virus in the ethnic minority populations in Yunnan, China.
Feng Y; Feng YM; Wang S; Xu F; Zhang X; Zhang C; Jia Y; Yang W; Xia X; Yin J
PLoS One; 2018; 13(5):e0197577. PubMed ID: 29787589
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China.
Bai MJ; Zhou N; Dong W; Li GX; Cong W; Zhu XQ
Int J Infect Dis; 2018 Jun; 71():42-47. PubMed ID: 29656134
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and risk factors of Hepatitis E virus infection among pregnant women attending antenatal care in health facilities of Tigray, Northern Ethiopia.
Niguse S; Hailekiros H; Buruh G; Dejene T; Berhe N; Asmelash T
J Med Virol; 2018 Aug; 90(8):1364-1369. PubMed ID: 29663452
[TBL] [Abstract][Full Text] [Related]
10. [A sero-epidemiological study of hepatitis E among general population in Shandong Province of China in 2014].
Yan BY; Zhang L; Lyu JJ; Feng Y; Liu JY; Wu WL; Song LZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):587-592. PubMed ID: 28693081
[No Abstract] [Full Text] [Related]
11. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic.
Lin CC; Wu JC; Chang TT; Chang WY; Yu ML; Tam AW; Wang SC; Huang YH; Chang FY; Lee SD
J Clin Microbiol; 2000 Nov; 38(11):3915-8. PubMed ID: 11060044
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia.
Abebe M; Ali I; Ayele S; Overbo J; Aseffa A; Mihret A
PLoS One; 2017; 12(6):e0180078. PubMed ID: 28650982
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis E virus infection in HIV-infected patients: A large cohort study in Yunnan province, China.
Zhou S; Ren L; Xia X; Miao Z; Huang F; Li Y; Zhu M; Xie Z; Xu Y; Qian Y; Pan Q; Wang K
J Med Virol; 2018 Jun; 90(6):1121-1127. PubMed ID: 29457639
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiology and molecular characterization of hepatitis E virus in Jilin, China.
Zhu G; Qu Y; Jin N; Sun Z; Liu T; Lee H; Tian M; Wang T
Infection; 2008 Mar; 36(2):140-6. PubMed ID: 18330507
[TBL] [Abstract][Full Text] [Related]
16. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus.
Süer K; Güvenir M; Aykaç A
Pol J Microbiol; 2018; 67(4):525-528. PubMed ID: 30550239
[TBL] [Abstract][Full Text] [Related]
17. Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus.
Li TC; Zhang J; Shinzawa H; Ishibashi M; Sata M; Mast EE; Kim K; Miyamura T; Takeda N
J Med Virol; 2000 Nov; 62(3):327-33. PubMed ID: 11055242
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.
Zhang L; Jiang Z; Lv J; Liu J; Yan B; Feng Y; Li L; Zhang G; Wang F; Xu A
BMC Infect Dis; 2018 Feb; 18(1):75. PubMed ID: 29433428
[TBL] [Abstract][Full Text] [Related]
20. Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India.
Mathur P; Arora NK; Panda SK; Kapoor SK; Jailkhani BL; Irshad M
Indian Pediatr; 2001 May; 38(5):461-75. PubMed ID: 11359972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
